REGN10933 + REGN10987
R10933-10987-COV-2069
Phase 3 small_molecule completed
Quick answer
REGN10933 + REGN10987 for Healthy Participants is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Healthy Participants
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed